MOBI MOBI
Company Profile ↓Company Overview
MOBI (MOBI) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 104.8% CAGR over the past five years.
Recent Developments
- Dec 2025 Revenue of $32.04M (+104.8% YoY); net profit $-46.50M.
- Trailing 12 Months Year-on-year growth — revenue +104.8%.
- 5-Year Trend Long-term compounding — revenue CAGR 104.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 104.81% |
| 1 Year: | 104.81% |
Stock Price Performance
| 1 Year: | +4.26% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | -0.81% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- RSI (14)54.06 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 104.8% over 5 years.
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue | 5.66M | 12.07M |
| Gross Profit | 4.65M | 9.94M |
| Operating Income | -10.30M | -16.94M |
| Net Income | -10.65M | -17.74M |
| Diluted EPS | -12.97 | -19.30 |
| R&D Expense | 1.35M | 1.69M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Revenue | 15.64M | 32.04M |
| Cost of Revenue | 3.19M | 6.07M |
| Gross Profit | 12.45M | 25.98M |
| Operating Expenses | 36.69M | 72.34M |
| Operating Income | -24.24M | -46.37M |
| EBITDA | -23.50M | -45.37M |
| Interest Expense | 969.92K | 967.37K |
| Pretax Income | -24.59M | -46.49M |
| Tax Provision | 13.91K | 5.45K |
| Net Income | -24.60M | -46.50M |
| Diluted EPS | -1.08 | -0.02 |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Operating Cash Flow | -24.32M | -45.69M |
| Investing Cash Flow | -40.85K | -364.41K |
| Financing Cash Flow | 15.66M | 65.03M |
| Capital Expenditure | -40.85K | -364.41K |
| Free Cash Flow | -24.36M | -46.06M |
| Net Change in Cash | -8.70M | 18.97M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Gross Margin % | 79.6% | 81.1% |
| Operating Margin % | -154.9% | -144.7% |
| Net Margin % | -157.3% | -145.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MOBI
Mobia Medical Appoints Myriam Curet, M.D., to its Board of Directors
AUSTIN, Texas, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced the appoint…
Mobia Medical to Report Second Quarter 2026 Financial Results on August 11, 2026
AUSTIN, Texas, July 21, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that the Co…
Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors
AUSTIN, Texas, July 15, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced the appoint…
Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim® Paired VNS™ Therapy
Findings published in Neurology® show improvements in upper-limb motor function, activities of daily living, and quality of life were sustained for at least two yearsAUSTIN, Texas, July 14, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasd…
Mobia Medical Announces Vivistim® Procedure Remains Assigned to New Technology APC 1580 under CMS Proposed 2027 Hospital Outpatient Prospective Payment System Rule
AUSTIN, Texas, July 02, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that the Ce…
Mobia Medical poised for commercial expansion, BofA says in initial coverage
Mobia Medical (NASDAQ:MOBI) was initiated with a ‘Buy’ rating and a $16 price target by Bank of America, which cited the company's growth potential in stroke recovery treatment and a large addressable market for its Vivistim system. Mobia's…
MOBI — Frequently Asked Questions
What is the current share price of MOBI?
As of 2026-08-05 17:25 PDT, MOBI trades at $12.25 on NASDAQ/NYSE. Its 52-week range is $10.43 to $14.63.
What is the P/E ratio of MOBI?
MOBI trades at a trailing price-to-earnings (P/E) ratio of -612.50.
Is MOBI a good stock to buy?
This page provides a data-driven analysis of MOBI, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.